OBJECTIVES: Primary care providers often care for men with prostate cancer due to its prolonged clinical course and an increasing number of survivors. However, their attitudes and care patterns are inadequately studied. In this context, we surveyed primary care providers regarding the scope of their prostate cancer survivorship care. METHODS: The 2006 Early Detection and Screening for Prostate Cancer Knowledge, Attitudes and Practice Survey conducted by the Michigan Public Health Institute investigated the beliefs and practice patterns of primary care providers in Michigan. We evaluated responses from 902 primary care providers regarding the timing and content of their prostate cancer survivorship care and relationships with specialty care. RESULTS: Two-thirds (67.6%) of providers cared for men during and after prostate cancer treatment. Providers routinely inquired about incontinence, impotence and bowel problems (83.3%), with a few (14.2%) using surveys to measure symptoms. However, only a minority felt 'very comfortable' managing the side effects of prostate cancer treatment. Clear plans (76.1%) and details regarding management of treatment complications (65.2%) from treating specialists were suboptimal. Nearly one-half (45.1%) of providers felt it was equally appropriate for them and treating specialists to provide prostate cancer survivorship care. CONCLUSIONS: Primary care providers reported that prostate cancer survivorship care is prevalent in their practice, yet few felt very comfortable managing side effects of prostate cancer treatment. To improve quality of care, implementing prostate cancer survivorship care plans across specialties, or transferring primary responsibility to primary care providers through survivorship guidelines, should be considered.
OBJECTIVES: Primary care providers often care for men with prostate cancer due to its prolonged clinical course and an increasing number of survivors. However, their attitudes and care patterns are inadequately studied. In this context, we surveyed primary care providers regarding the scope of their prostate cancer survivorship care. METHODS: The 2006 Early Detection and Screening for Prostate Cancer Knowledge, Attitudes and Practice Survey conducted by the Michigan Public Health Institute investigated the beliefs and practice patterns of primary care providers in Michigan. We evaluated responses from 902 primary care providers regarding the timing and content of their prostate cancer survivorship care and relationships with specialty care. RESULTS: Two-thirds (67.6%) of providers cared for men during and after prostate cancer treatment. Providers routinely inquired about incontinence, impotence and bowel problems (83.3%), with a few (14.2%) using surveys to measure symptoms. However, only a minority felt 'very comfortable' managing the side effects of prostate cancer treatment. Clear plans (76.1%) and details regarding management of treatment complications (65.2%) from treating specialists were suboptimal. Nearly one-half (45.1%) of providers felt it was equally appropriate for them and treating specialists to provide prostate cancer survivorship care. CONCLUSIONS: Primary care providers reported that prostate cancer survivorship care is prevalent in their practice, yet few felt very comfortable managing side effects of prostate cancer treatment. To improve quality of care, implementing prostate cancer survivorship care plans across specialties, or transferring primary responsibility to primary care providers through survivorship guidelines, should be considered.
Authors: K Robin Yabroff; William W Davis; Elizabeth B Lamont; Angela Fahey; Marie Topor; Martin L Brown; Joan L Warren Journal: J Natl Cancer Inst Date: 2007-01-03 Impact factor: 13.506
Authors: Bruce J Trock; Misop Han; Stephen J Freedland; Elizabeth B Humphreys; Theodore L DeWeese; Alan W Partin; Patrick C Walsh Journal: JAMA Date: 2008-06-18 Impact factor: 56.272
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: Winson Y Cheung; Bridget A Neville; Danielle B Cameron; E Francis Cook; Craig C Earle Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544
Authors: Deborah K Mayer; Adrian Gerstel; Annmarie Lee Walton; Tammy Triglianos; Teresa E Sadiq; Nikki A Hawkins; Janine M Davies Journal: Oncol Nurs Forum Date: 2014-05 Impact factor: 2.172
Authors: Ashraf Almatar; Suzanne Richter; Nafisha Lalani; Jackie L Bender; David Wiljer; Nour Alkazaz; Laura Legere; Manjula Maganti; Srikala S Sridhar; Pamela P Catton; Michael A S Jewett Journal: Can Urol Assoc J Date: 2014-11 Impact factor: 1.862
Authors: SarahMaria Donohue; James E Haine; Zhanhai Li; Elizabeth R Trowbridge; Sandra A Kamnetz; David A Feldstein; James M Sosman; Lee G Wilke; Mary E Sesto; Amye J Tevaarwerk Journal: J Cancer Educ Date: 2019-02 Impact factor: 2.037
Authors: Lauren P Wallner; Yun Li; Allison K C Furgal; Christopher R Friese; Ann S Hamilton; Kevin C Ward; Reshma Jagsi; Steven J Katz; Sarah T Hawley Journal: J Clin Oncol Date: 2017-07-12 Impact factor: 50.717
Authors: May Darwish-Yassine; Manijeh Berenji; Diane Wing; Glenn Copeland; Raymond Y Demers; Carol Garlinghouse; Angela Fagerlin; Gail E Newth; Laurel Northouse; Margaret Holmes-Rovner; David Rovner; Jerry Sims; John T Wei Journal: J Cancer Surviv Date: 2013-11-10 Impact factor: 4.442
Authors: Fiona Crawford-Williams; Belinda Goodwin; Sonja March; Michael J Ireland; Melissa K Hyde; Suzanne K Chambers; Joanne F Aitken; Jeff Dunn Journal: Support Care Cancer Date: 2018-04-25 Impact factor: 3.603
Authors: J Cockle-Hearne; F Charnay-Sonnek; L Denis; H E Fairbanks; D Kelly; S Kav; K Leonard; E van Muilekom; P Fernandez-Ortega; B T Jensen; S Faithfull Journal: Br J Cancer Date: 2013-09-24 Impact factor: 7.640